Dangers of Weight Loss Drugs: What the Risks Really Are (October 2026)

01 · The core answer

What are the dangers of weight loss drugs?

The dangers fall into four groups: side effects of the medicine itself, interactions with other medicines, risks from products that are not what they claim to be, and risks from using any treatment without proper supervision. The first two are known, documented and managed by prescribers. The last two are where most serious harm happens, and they are largely avoidable.

Mounjaro is a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹ Because it is licensed, its risks have been studied, written into the product information and made public. That is a very different position from a product with no licence, no label and no accountable manufacturer.

Honest framing matters here. No effective medicine is risk-free, and a page that says otherwise is not worth trusting. Equally, a page that treats every weight loss drug as equally dangerous is not helpful either.

02 · Your decision

Is this relevant to you, and what should you do next?

It is relevant if you are considering any weight loss medicine, already taking one, or have seen an offer that sounds too easy. Your next step is to ask a simple question: would a registered prescriber review my health history before I receive this?

If the answer is no, treat that as the danger in itself. Our overview of weight loss drugs explains which treatments are licensed in the UK and how they differ.

If you want a regulated route, our weight loss clinic starts with a free online consultation reviewed by a GPhC-registered prescriber, and unsuitable orders are refunded automatically.

03 · Side effects and what to do

Side effects: what to expect and what to do

Every licensed Mounjaro pen comes with a patient information leaflet that lists its side effects, and the full list sits in the SmPC.¹¹³ Read it before your first dose, not after a problem starts. Like all medicines, Mounjaro can cause side effects, and most are digestive. The most common, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions. Side effects are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks as the body adjusts.

The practical advice is consistent across licensed medicines. Tell your prescriber about any symptom that is new, severe or does not settle. Do not wait for a scheduled review if something feels seriously wrong, and get medical help straight away for anything alarming.

You can also report a suspected side effect yourself through the MHRA Yellow Card scheme, whether it is listed in the leaflet or not.¹⁹ Reports help regulators spot patterns that individual trials miss.

Our own aftercare includes ongoing monthly reviews, dose titration and follow-up assessments by the prescribing team, plus side-effect support. That is the safeguard that unregulated sellers cannot offer. For a closer look at one medicine, see our guide to the dangers of Mounjaro.

04 · Who should not take them

Who should not take weight loss drugs

Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation. That is exactly why a prescription exists. A person reading an article cannot be assessed; a prescriber with your history in front of them can.

Mounjaro is licensed for weight management in adults, which means it is not a treatment for children or for people who simply want to lose a little weight with no clinical need. Within the NHS pathway, NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition.⁴ Private prescribers apply the licensed criteria and their own clinical judgement.

If you are asking “who should not take the weight loss pill”, the honest answer is that it depends on the specific tablet. Each has its own product information, and none of them should be started without a prescriber’s review.

Be especially careful to disclose pregnancy plans, existing medical conditions, anything you take for diabetes, and any history you think might be relevant. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Withholding information is a danger that no label can fix. If you are unsure whether something matters, say it anyway.

05 · Interactions to know

Interactions with other medicines

Mounjaro can reduce the absorption of oral contraceptives, because it slows how quickly the stomach empties.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you use an oral contraceptive, switch to a non-oral method or add a barrier method for 4 weeks after starting and for 4 weeks after each dose increase, and tell your prescriber before your first dose.

The same slowed stomach emptying is part of how tirzepatide works. It activates the GIP and GLP-1 receptors, which help regulate appetite, slow stomach emptying and improve the way the body responds to insulin.¹ It also explains why timing and absorption of other oral medicines are worth discussing.

If you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar.¹ That does not mean the medicines cannot be used together. It means a prescriber should plan the doses and monitoring rather than leaving you to guess.

Give your prescriber a complete list: prescription medicines, over-the-counter products, supplements and herbal remedies. Supplements are not harmless simply because they are sold freely, and none of them has the tested, standardised dosing of a licensed medicine. For the wider picture of this drug class, our guide to the dangers of GLP-1 medicines goes further.

06 · Unregulated sellers and fakes

The danger of unregulated and counterfeit products

The most preventable danger is buying a weight loss product from a seller with no accountability. Anyone offering to supply a prescription medicine without a consultation or prescription is operating outside the system designed to protect you. The MHRA publishes counterfeit medicine alerts for exactly this reason.⁷

The risks are practical. A counterfeit or diluted pen may contain the wrong amount of active ingredient, or none. It may have been stored badly. It may arrive with no needles, no sharps bin and no instructions. If you react badly, nobody who knows your history is looking after you.

Warning signs include:

• No questions about your health before you can buy.
• Dramatic weight-loss claims and promises of specific results.
• Prices far below what the licensed medicine is sold for across the UK pharmacies we track.
• No pharmacy registration you can verify.
• Social media or messaging-app sales.

You can check any UK pharmacy on the GPhC public register.¹² Ours is GPhC-registered, number 9012878, and we supply Mounjaro through official LillyDirect supply, direct from Eli Lilly’s UK distribution, as genuine KwikPens.

Supplements marketed as natural alternatives deserve the same caution. They are low-cost supplements with no clinical oversight, and the dramatic claims attached to them are not backed by the trial evidence that licensed medicines have. Their dosing is not standardised, so there is no reliable way to know what you are taking.

07 · Storage and handling risks

Storage and handling mistakes

A medicine can become unsafe through poor handling even when it is genuine. Unopened Mounjaro pens should be stored in the fridge at 2–8°C until first use, and they keep until the printed expiry date.¹¹³

Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen.¹ Beyond that window, sterility and potency are no longer assured. If an unopened pen has been left out of the fridge, do not guess; contact the pharmacy that supplied it before using it.

Follow the pen’s instructions for injecting. Do not share pens, even between people who take the same medicine. Dispose of used needles in a sharps bin, which is included with every order we send, together with injection guidance.

Delivery matters too. Pens bought from an unknown source may have spent days without cold-chain protection, and you would never know.

08 · Long-term effects and stopping

Long-term effects and stopping treatment

Long-term safety is a fair question, and the honest answer is that it is monitored continuously rather than settled once. Regulators track safety information after a medicine is licensed, and the SmPC is updated as evidence grows.¹ Check the current leaflet instead of relying on a news story or a forum thread.

If you stop, tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.¹⁴

People stop for many reasons: side effects, cost, reaching a goal, a change in health or a change in plans. Stopping is a decision to make with your prescriber.

09 · Honest context on benefit

Weighing the dangers against the benefit

Risk only makes sense next to benefit. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary.

Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² A medicine that is taken without that support, or by someone who does not have a clinical reason for it, shifts the balance of risk and benefit in the wrong direction.

For someone with a weight-related health condition, the case for treatment can be strong. For someone who is already at a healthy weight, the same medicine carries risk with little to gain. That is why a prescriber’s judgement is part of the safety system, not a formality.

NHS access exists too. Mounjaro is available on the NHS, but access is being phased in over several years, and the primary-care rollout began in June 2025 with the highest-need groups first.⁴⁶ Many people who meet the licensed criteria choose regulated private treatment rather than waiting.

10 · Common questions answered

What people ask about Ozempic and similar drugs

Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. The licensed weight-management options are Mounjaro (tirzepatide) and Wegovy (semaglutide 2.4mg).

The reliable route is the same for every product: read the SmPC and patient leaflet for the exact medicine, ask the prescriber who knows your history, and report concerns through the Yellow Card scheme.¹⁹

If you notice a new symptom of any kind that you think might be linked to a treatment, do not rely on internet reports. Mention it to your prescriber.

For comparisons between treatment types, our guide to the dangers of weight loss injections covers injectables in more detail, and our pages on the fen-fen weight loss drug and amphetamine drugs for weight loss look at older approaches.

11 · Choosing a safer route

How to choose a safer route to treatment

A safer route has a few consistent features. It begins with a consultation, it involves a registered prescriber, it uses a verifiable pharmacy, and it includes follow-up. Without those, you are relying on luck.

Before you buy from anyone, check these points:

• The pharmacy appears on the GPhC register.¹²
• A prescriber reviews your answers before anything is dispensed.
• The medicine is a licensed product with a patient leaflet.
• There is a real support route if you have a problem, with named contact methods.
• Pricing is clear, with no hidden fees.

Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Repeat orders re-check suitability, and nothing is shipped automatically. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through account chat or on 0333 207 0413.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹